| Identification | Back Directory | [Name]
6-Methyl-9-(2-C-Methyl-2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)purine | [CAS]
2095417-61-9 | [Synonyms]
2’-β-C-Methyl-2’,3’,5’-tri-O-acetyl-β-D-6-methylpurine riboside
2’-β-C-Methyl-2’,3’,5’-tri-O-benzoyl-β-D-6-methylpurine riboside
9-(2',3',5'-Tri-O-benzoyl-2'-C-methyl-b-D-ribofuranosyl)6-methylpurine
6-Methyl-9-(2-C-Methyl-2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)purine
6-Methyl-9-(2-C-methyl-2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)purine, 2’-C-Methyl-2’,3’,5’-tri-O-acetyl-beta-D-6-methylpurine riboside | [Molecular Formula]
C33H28N4O7 | [MDL Number]
MFCD25542511 | [MOL File]
2095417-61-9.mol | [Molecular Weight]
592.61 |
| Hazard Information | Back Directory | [Uses]
6-Methyl-9-(2-β-C-methyl-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
T&W GROUP
|
| Tel: |
021-61551611 13296011611 |
| Website: |
www.trustwe.com/ |
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList1701258/0_EN.htm |
|